Inflammatory bowel disease and T cell lymphopenia in G6PC3 deficiency

Philippe Bégin1, Natalie Patey, Pascal Mueller

  • 1Department of Pediatrics, CHU Sainte-Justine and Université de Montréal, Montreal, Canada.

Insights

G6PC3 deficiency can cause T cell lymphopenia and inflammatory bowel disease in children. Early diagnosis is crucial for managing congenital neutropenia and gastrointestinal symptoms.

Area of Science:

  • Immunology
  • Genetics
  • Pediatrics

Background:

  • G6PC3 deficiency classically presents with congenital neutropenia and developmental defects.
  • This syndrome's heterogeneity necessitates investigating broader clinical manifestations.
  • T cell lymphopenia and inflammatory bowel disease are less common but significant associations.

Purpose of the Study:

  • To investigate T cell lymphopenia and inflammatory bowel disease in a child with G6PC3 deficiency.
  • To analyze the genetic basis (compound heterozygous mutations) of G6PC3 deficiency in this patient.
  • To characterize the immunophenotype and clinical presentation.

Main Methods:

  • Histological examination of biopsy specimens.
  • Immunophenotyping and lymphocyte proliferation assays.
  • Measurement of immunoglobulin levels and vaccine responses.

Main Results:

  • The patient exhibited persistent global T cell lymphopenia, with significantly reduced naive CD4 T cells.
  • Gastrointestinal lesions resembled Crohn's disease but lacked granulomas.
  • The inflammatory bowel disease responded to infliximab therapy, with polyclonal hypergammaglobulinemia G observed.

Conclusions:

  • G6PC3 deficiency should be considered in patients with congenital neutropenia and gastrointestinal issues.
  • T cell lymphopenia can be a presenting feature of G6PC3 deficiency.
  • Cellular immunodeficiency screening, including T cell phenotyping, is recommended for confirmed cases.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...